BRPI0412374A - peptìdeos de ligação com emissores que produzem uma variação nas propriedades de emissão do espectro do emissor - Google Patents

peptìdeos de ligação com emissores que produzem uma variação nas propriedades de emissão do espectro do emissor

Info

Publication number
BRPI0412374A
BRPI0412374A BRPI0412374-3A BRPI0412374A BRPI0412374A BR PI0412374 A BRPI0412374 A BR PI0412374A BR PI0412374 A BRPI0412374 A BR PI0412374A BR PI0412374 A BRPI0412374 A BR PI0412374A
Authority
BR
Brazil
Prior art keywords
emitter
variation
produce
binding peptides
emission properties
Prior art date
Application number
BRPI0412374-3A
Other languages
English (en)
Inventor
Michael Schirner
Kai Licha
Andreas Menrad
Stefanie Urlinger
Cornelia Hanel
Bodo Brocks
Original Assignee
Schering Ag
Morphosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2003131054 external-priority patent/DE10331054A1/de
Application filed by Schering Ag, Morphosys Ag filed Critical Schering Ag
Publication of BRPI0412374A publication Critical patent/BRPI0412374A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"PEPTìDEOS DE LIGAçãO COM EMISSORES QUE PRODUZEM UMA VARIAçãO NAS PROPRIEDADES DE EMISSãO DO ESPECTRO DO EMISSOR". A presente invenção refere-se a peptídeos de ligação com emissor que produzem uma variação nas propriedades de emissão do espectro do emissor no caso de uma interação de uma bolsa de ligação com antígeno com o emissor. Os peptídeos de ligação com emissor são em particular componentes de anticorpos e fragmentos de anticorpo.
BRPI0412374-3A 2003-07-09 2004-07-09 peptìdeos de ligação com emissores que produzem uma variação nas propriedades de emissão do espectro do emissor BRPI0412374A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2003131054 DE10331054A1 (de) 2003-07-09 2003-07-09 Emitter-bindende Peptide die eine Veränderung der spektralen Emissionseigenschaften des Emitters bewirken
US48723403P 2003-07-16 2003-07-16
PCT/EP2004/007596 WO2005005483A1 (de) 2003-07-09 2004-07-09 Emitter-bindende peptide, die eine veränderung der spektralen emissionseigenschaften des emitters bewirken

Publications (1)

Publication Number Publication Date
BRPI0412374A true BRPI0412374A (pt) 2006-09-05

Family

ID=34066308

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412374-3A BRPI0412374A (pt) 2003-07-09 2004-07-09 peptìdeos de ligação com emissores que produzem uma variação nas propriedades de emissão do espectro do emissor

Country Status (12)

Country Link
US (1) US20050064512A1 (pt)
EP (2) EP1641829A1 (pt)
JP (1) JP2007526750A (pt)
KR (1) KR20060067949A (pt)
AT (1) ATE470678T1 (pt)
AU (1) AU2004255358A1 (pt)
BR (1) BRPI0412374A (pt)
CA (1) CA2531962A1 (pt)
DE (1) DE502004011269D1 (pt)
EA (1) EA010289B1 (pt)
IL (1) IL172548A0 (pt)
WO (2) WO2005005482A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2629094A1 (en) * 2007-01-24 2013-08-21 Carnegie Mellon University Optical biosensors
US8426153B2 (en) * 2007-12-03 2013-04-23 Carnegie Mellon University Linked peptides fluorogenic biosensors
EP2515110B1 (en) * 2009-11-19 2015-03-25 Ushio Denki Kabushiki Kaisha Fluoroimmunoassay method
CN102993305B (zh) * 2012-11-16 2015-05-13 上海赛伦生物技术有限公司 人源抗人表皮生长因子受体抗体及其编码基因与应用
US9862682B2 (en) 2016-01-08 2018-01-09 BroadPharm Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US5569587A (en) * 1986-04-18 1996-10-29 Carnegie Mellon University Method for labeling and detecting materials employing luminescent arysulfonate cyanine dyes
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US6492160B1 (en) * 1991-05-15 2002-12-10 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
ATE207080T1 (de) * 1991-11-25 2001-11-15 Enzon Inc Multivalente antigen-bindende proteine
US6437099B1 (en) * 1998-01-07 2002-08-20 Hamamatsu Photonics K.K. Fluorescene—activating antisera and IgG fraction therefrom
AU2001295042A1 (en) * 2000-09-13 2002-03-26 The Scripps Research Institute Anti-stilbene antibodies
KR101027213B1 (ko) * 2002-09-19 2011-04-06 하마마츠 포토닉스 가부시키가이샤 형광화 항체를 이용한 형광 분석 방법

Also Published As

Publication number Publication date
EP1641829A1 (de) 2006-04-05
ATE470678T1 (de) 2010-06-15
JP2007526750A (ja) 2007-09-20
HK1094209A1 (zh) 2007-03-23
EP1641830B1 (de) 2010-06-09
KR20060067949A (ko) 2006-06-20
EP1641830A1 (de) 2006-04-05
EA200600158A1 (ru) 2006-08-25
IL172548A0 (en) 2006-04-10
US20050064512A1 (en) 2005-03-24
CA2531962A1 (en) 2005-01-20
WO2005005482A1 (de) 2005-01-20
AU2004255358A1 (en) 2005-01-20
WO2005005483A1 (de) 2005-01-20
DE502004011269D1 (de) 2010-07-22
EA010289B1 (ru) 2008-08-29

Similar Documents

Publication Publication Date Title
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
CY1116632T1 (el) Εξουδετερωτες αντισωματων του τελεστη διεγερσης αποικιων κοκκιοκυτταρων μακροφαγων ανθρωπου
CY1119127T1 (el) Επιτοποι σκληροστινης
WO2005003169A3 (en) Modified antibody fab fragments
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
BRPI0314814B8 (pt) anticorpo compreendendo uma variante de fc
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
DE69433663D1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
CL2010000788A1 (es) Anticuerpo monoclonal o fragmento de union a antigeno del mismo que se une a integrina alfa-v-beta-6; composicion farmaceutica que lo comprende; uso para tratar o prevenir fibrosis, psoriasis, cancer, daño agudo de pulmon y sindrome de alpont; uso para detectar integrina alfa-v-beta-6 (div. sol. no. 513-03).
BRPI0406800A (pt) Peptìdio dimerizado
ATE535547T1 (de) Vernetzte antikörper
CR20120587A (es) Moléculas de unión al antígeno que fijan egfr, vectores que las codifican y uso de las mismas
MX338940B (es) Identificacion de epitopos ige novedosos.
PT1639011E (pt) Anticorpos (dab) de domínio único peguilados
BRPI0410031A (pt) variantes fc otimizadas e métodos para sua geração
BR0209792A (pt) Anticorpos para vla-1
AR054474A1 (es) Formulacion de anticuerpos estables
CR8317A (es) Anticuerpos dirigidos a m-csf
CY1115147T1 (el) Εξουδετερωτικα αντισωματα που εχουν ειδικοτητα για ανθρωπινη il-17
NO20060843L (no) RG1-antistoffer og anvendelser derav
HRP20050922A2 (en) Recombinant antibodies and fragments which recognize n-glycolil-gm3 ganglioside and its use in the diagnosis and treatment of tumours
GB2396556B (en) Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation
CY1106056T1 (el) Παραγωγα 2-αμινο-2-αλκυλ-5-επτενοϊκου και επτυνοϊκου οξεος χρησιμα σαν αναστολεις συνθασης νιτρικου οξειδιου
ATE527284T1 (de) Modifizierte antikörper-fragmente
ATE407147T1 (de) Fab-fragmente humaner monoklonaler antikörper mit neutralisierender aktivität gegen das hcv e2 glycoprotein

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.